Literature DB >> 23432593

Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement.

Deborah S Hasin1, Efrat Aharonovich, Ann O'Leary, Eliana Greenstein, Martina Pavlicova, Srikesh Arunajadai, Rachel Waxman, Milton Wainberg, John Helzer, Barbara Johnston.   

Abstract

AIMS: In HIV-infected individuals, heavy drinking compromises survival. In HIV primary care, the efficacy of brief motivational interviewing (MI) to reduce drinking is unknown, alcohol-dependent patients may need greater intervention and resources are limited. Using interactive voice response (IVR) technology, HealthCall was designed to enhance MI via daily patient self-monitoring calls to an automated telephone system with personalized feedback. We tested the efficacy of MI-only and MI+HealthCall for drinking reduction among HIV primary care patients.
DESIGN: Parallel random assignment to control (n = 88), MI-only (n = 82) or MI+HealthCall (n = 88). Counselors provided advice/education (control) or MI (MI-only or MI+HealthCall) at baseline. At 30 and 60 days (end-of-treatment), counselors briefly discussed drinking with patients, using HealthCall graphs with MI+HealthCall patients.
SETTING: Large urban HIV primary care clinic. PARTICIPANTS: Patients consuming ≥4 drinks at least once in prior 30 days. MEASUREMENTS: Using time-line follow-back, primary outcome was number of drinks per drinking day, last 30 days.
FINDINGS: End-of-treatment number of drinks per drinking day (NumDD) means were 4.75, 3.94 and 3.58 in control, MI-only and MI+HealthCall, respectively (overall model χ(2) , d.f. = 9.11,2, P = 0.01). For contrasts of NumDD, P = 0.01 for MI+HealthCall versus control; P = 0.07 for MI-only versus control; and P = 0.24 for MI+HealthCall versus MI-only. Secondary analysis indicated no intervention effects on NumDD among non-alcohol-dependent patients. However, for contrasts of NumDD among alcohol-dependent patients, P < 0.01 for MI+HealthCall versus control; P = 0.09 for MI-only versus control; and P = 0.03 for MI+HealthCall versus MI-only. By 12-month follow-up, although NumDD remained lower among alcohol-dependent patients in MI+HealthCall than others, effects were no longer significant.
CONCLUSIONS: For alcohol-dependent HIV patients, enhancing MI with HealthCall may offer additional benefit, without extensive additional staff involvement.
© 2013 The Authors, Addiction © 2013 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2013        PMID: 23432593      PMCID: PMC3755729          DOI: 10.1111/add.12127

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  36 in total

Review 1.  Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations.

Authors:  Anne Moyer; John W Finney; Carolyn E Swearingen; Pamela Vergun
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

2.  Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya.

Authors:  Rebecca K Papas; John E Sidle; Benson N Gakinya; Joyce B Baliddawa; Steve Martino; Michael M Mwaniki; Rogers Songole; Otieno E Omolo; Allan M Kamanda; David O Ayuku; Claris Ojwang; Willis D Owino-Ong'or; Magdalena Harrington; Kendall J Bryant; Kathleen M Carroll; Amy C Justice; Joseph W Hogan; Stephen A Maisto
Journal:  Addiction       Date:  2011-08-18       Impact factor: 6.526

3.  Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods.

Authors:  Patricia R Houck; Sati Mazumdar; Tulay Koru-Sengul; Gong Tang; Benoit H Mulsant; Bruce G Pollock; Charles F Reynolds
Journal:  Psychiatry Res       Date:  2004-12-15       Impact factor: 3.222

4.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

5.  HIV care providers' implementation of routine alcohol reduction support for their patients.

Authors:  Shiela M Strauss; Nelson J Tiburcio; Corrine Munoz-Plaza; Marya Gwadz; Joseph Lunievicz; Andrew Osborne; Diana Padilla; Mary McCarty-Arias; Robert Norman
Journal:  AIDS Patient Care STDS       Date:  2009-03       Impact factor: 5.078

6.  Improving endoscopy completion: effectiveness of an interactive voice response system.

Authors:  Joan M Griffin; Erin M Hulbert; Sally W Vernon; David Nelson; Emily M Hagel; Sean Nugent; Alisha Baines Simon; Ann Bangerter; Michelle van Ryn
Journal:  Am J Manag Care       Date:  2011-03       Impact factor: 2.229

7.  A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting.

Authors:  E Aharonovich; M L Hatzenbuehler; B Johnston; A O'Leary; J Morgenstern; M L Wainberg; P Yao; J E Helzer; D S Hasin
Journal:  AIDS Care       Date:  2006-08

8.  Can you hear me now? Limited use of technology among an urban HIV-infected cohort.

Authors:  E Shacham; K Stamm; E T Overton
Journal:  AIDS Care       Date:  2009-08

9.  Missing Data in Longitudinal Trials - Part B, Analytic Issues.

Authors:  Juned Siddique; C Hendricks Brown; Donald Hedeker; Naihua Duan; Robert D Gibbons; Jeanne Miranda; Philip W Lavori
Journal:  Psychiatr Ann       Date:  2008-12-01

Review 10.  Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Michael R Polen; Carla A Green; Tracy Orleans; Jonathan Klein
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

View more
  70 in total

1.  Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.

Authors:  Christopher W Kahler; Tao Liu; Patricia A Cioe; Vaughn Bryant; Megan M Pinkston; Erna M Kojic; Nur Onen; Jason V Baker; John Hammer; John T Brooks; Pragna Patel
Journal:  AIDS Behav       Date:  2017-07

2.  The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection.

Authors:  Jennifer C Elliott; Lacey Critchley; Daniel J Feaster; Deborah S Hasin; Raul N Mandler; Georgina Osorio; Allan E Rodriguez; Carlos Del Rio; Lisa R Metsch
Journal:  Drug Alcohol Depend       Date:  2019-06-05       Impact factor: 4.492

3.  Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial.

Authors:  Christopher W Kahler; David W Pantalone; Nadine R Mastroleo; Tao Liu; Gerald Bove; Bharat Ramratnam; Peter M Monti; Kenneth H Mayer
Journal:  J Consult Clin Psychol       Date:  2018-08

4.  A Cross-Sectional Study of Depressive Symptoms and Risky Alcohol Use Behaviors Among HIV Primary Care Patients in New York City.

Authors:  Yasemin Algur; Jennifer C Elliott; Efrat Aharonovich; Deborah S Hasin
Journal:  AIDS Behav       Date:  2018-05

5.  Drinking motives as prospective predictors of outcome in an intervention trial with heavily drinking HIV patients.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Milton Wainberg; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2013-11-05       Impact factor: 4.492

6.  Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report.

Authors:  Judith A Hahn; Nneka I Emenyonu; Robin Fatch; Winnie R Muyindike; Allen Kekiibina; Adam W Carrico; Sarah Woolf-King; Stephen Shiboski
Journal:  Addiction       Date:  2015-11-05       Impact factor: 6.526

7.  Association between change in self-efficacy to resist drinking and drinking behaviors among an HIV-infected sample: Results from a large randomized controlled trial.

Authors:  Nicole K Gause; Jennifer C Elliott; Erin Delker; Malka Stohl; Deborah Hasin; Efrat Aharonovich
Journal:  J Health Psychol       Date:  2016-08-30

8.  Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients.

Authors:  Kathleen A McGinnis; Janet P Tate; Emily C Williams; Melissa Skanderson; Kendall J Bryant; Adam J Gordon; Kevin L Kraemer; Stephen A Maisto; Steven Crystal; David A Fiellin; Amy C Justice
Journal:  Drug Alcohol Depend       Date:  2016-09-22       Impact factor: 4.492

Review 9.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

10.  Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial.

Authors:  E Jennifer Edelman; Stephen A Maisto; Nathan B Hansen; Christopher J Cutter; James Dziura; Yanhong Deng; Lynn E Fiellin; Patrick G O'Connor; Roger Bedimo; Cynthia L Gibert; Vincent C Marconi; David Rimland; Maria C Rodriguez-Barradas; Michael S Simberkoff; Janet P Tate; Amy C Justice; Kendall J Bryant; David A Fiellin
Journal:  J Subst Abuse Treat       Date:  2019-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.